Search Results - "Ross, Christopher A."

Refine Results
  1. 1

    Huntington's disease: from molecular pathogenesis to clinical treatment by Ross, Christopher A, Dr, Tabrizi, Sarah J, FRCP

    Published in Lancet neurology (2011)
    “…Summary Huntington's disease is a progressive, fatal, neurodegenerative disorder caused by an expanded CAG repeat in the huntingtin gene, which encodes an…”
    Get full text
    Journal Article
  2. 2

    Transcriptome-wide discovery of microRNA binding sites in human brain by Boudreau, Ryan L, Jiang, Peng, Gilmore, Brian L, Spengler, Ryan M, Tirabassi, Rebecca, Nelson, Jay A, Ross, Christopher A, Xing, Yi, Davidson, Beverly L

    Published in Neuron (Cambridge, Mass.) (22-01-2014)
    “…The orchestration of brain function requires complex gene regulatory networks that are modulated, in part, by microRNAs (miRNAs). These noncoding RNAs…”
    Get full text
    Journal Article
  3. 3
  4. 4

    RAN Translation in Huntington Disease by Bañez-Coronel, Monica, Ayhan, Fatma, Tarabochia, Alex D, Zu, Tao, Perez, Barbara A, Tusi, Solaleh Khoramian, Pletnikova, Olga, Borchelt, David R, Ross, Christopher A, Margolis, Russell L, Yachnis, Anthony T, Troncoso, Juan C, Ranum, Laura P W

    Published in Neuron (Cambridge, Mass.) (18-11-2015)
    “…Huntington disease (HD) is caused by a CAG ⋅ CTG expansion in the huntingtin (HTT) gene. While most research has focused on the HTT polyGln-expansion protein,…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor by Eddings, Chelsy R., Arbez, Nicolas, Akimov, Sergey, Geva, Michal, Hayden, Michael R., Ross, Christopher A.

    Published in Neurobiology of disease (01-09-2019)
    “…Huntington's disease (HD) is a neurodegenerative disease caused by a CAG repeat expansion in the Huntingtin gene (HTT), translated into a Huntingtin protein…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells by Juopperi, Tarja A, Kim, Woon Ryoung, Chiang, Cheng-Hsuan, Yu, Huimei, Margolis, Russell L, Ross, Christopher A, Ming, Guo-li, Song, Hongjun

    Published in Molecular brain (21-05-2012)
    “…Huntington's Disease (HD) is a devastating neurodegenerative disorder that clinically manifests as motor dysfunction, cognitive impairment and psychiatric…”
    Get full text
    Journal Article
  12. 12

    Acute Kidney Injury Leads to Inflammation and Functional Changes in the Brain by MANCHANG LIU, YIDENG LIANG, CHIGURUPATI, Srinivasulu, LATHIA, Justin D, PLETNIKOV, Mikhail, ZHAOLI SUN, CROW, Michael, ROSS, Christopher A, MATTSON, Mark P, RABB, Hamid

    “…Although neurologic sequelae of acute kidney injury (AKI) are well described, the pathogenesis of acute uremic encephalopathy is poorly understood. This study…”
    Get full text
    Journal Article
  13. 13

    Kinase activity of mutant LRRK2 mediates neuronal toxicity by Smith, Wanli W, Ross, Christopher A, Pei, Zhong, Jiang, Haibing, Dawson, Valina L, Dawson, Ted M

    Published in Nature neuroscience (01-10-2006)
    “…Mutations in the the leucine-rich repeat kinase-2 (LRRK2) gene cause autosomal-dominant Parkinson disease and some cases of sporadic Parkinson disease. Here we…”
    Get full text
    Journal Article
  14. 14

    Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity by Arbez, Nicolas, Ratovitski, Tamara, Roby, Elaine, Chighladze, Ekaterine, Stewart, Jacqueline C., Ren, Mark, Wang, Xiaofang, Lavery, Daniel J., Ross, Christopher A.

    Published in The Journal of biological chemistry (24-11-2017)
    “…Huntington's disease (HD) is caused in large part by a polyglutamine expansion within the huntingtin (Htt) protein. Post-translational modifications (PTMs)…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism by Liu, Zhaohui, Yu, Yi, Li, Xueping, Ross, Christopher A., Smith, Wanli W.

    Published in Pharmacological research (01-05-2011)
    “…Parkinson's disease (PD) is a progressive neurodegenerative movement disorder characterized by selective loss of dopaminergic neurons and the presence of Lewy…”
    Get full text
    Journal Article
  18. 18

    Huntingtin protein interactions altered by polyglutamine expansion as determined by quantitative proteomic analysis by Ratovitski, Tamara, Chighladze, Ekaterine, Arbez, Nicolas, Boronina, Tatiana, Herbrich, Shelley, Cole, Robert N., Ross, Christopher A.

    Published in Cell cycle (Georgetown, Tex.) (15-05-2012)
    “…Huntington disease (HD) is a neurodegenerative disorder caused by an expansion of a polyglutamine repeat within the HD gene product, huntingtin. Huntingtin, a…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Parkinson's Disease-Associated Mutations in Leucine-Rich Repeat Kinase 2 Augment Kinase Activity by Andrew B. West, Darren J. Moore, Saskia Biskup, Artem Bugayenko, Smith, Wanli W., Ross, Christopher A., Dawson, Valina L., Dawson, Ted M.

    “…Mutations in the leucine-rich repeat kinase 2 gene (LRRK2) cause late-onset Parkinson's disease (PD) with a clinical appearance indistinguishable from…”
    Get full text
    Journal Article